Anna Sauerbier

Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade

Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Cognitive decline in Parkinson disease

Parkinson disease

Update on treatments for nonmotor symptoms of Parkinson's disease—an evidence‐based medicine review

International Parkinson and movement disorder society evidence‐based medicine review: Update on treatments for the motor symptoms of Parkinson's disease

Parkinson's disease

Ageing as a risk factor for neurodegenerative disease

Mitochondrial-Targeted Catalase

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

Non-motor features of Parkinson disease

How to diagnose parkinsonian central pain?

The neuropathological diagnosis of Alzheimer’s disease

Diagnosis and Treatment of Parkinson Disease

Therapeutic approaches in Parkinson's disease and related disorders

Neuropathic Pain: From Mechanisms to Treatment

Apomorphine in the treatment of Parkinson's disease: a review

New clinical trials for nonmotor manifestations of Parkinson's disease

New concepts in the pathogenesis and presentation of Parkinson’s disease

Non-oral dopaminergic therapies for Parkinson’s disease: current treatments and the future

The burden of non-motor symptoms in Parkinson's disease using a self-completed non-motor questionnaire: A simple grading system

Non motor subtypes and Parkinson's disease

Unravelling the nonmotor mysteries of Parkinson disease

A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short‐ and long‐acting dopamine agonists

King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation